D2C beauty brand SUGAR Cosmetics has closed a fresh funding round of ₹144.5 crore, led entirely by existing investor A91 Partners. The round values the company at roughly ₹755 crore a sharp comedown from the nearly ₹3,000 crore valuation it commanded back in 2022, when it raised a $50 million Series D.
That’s a valuation cut of about 75% in just three years, placing SUGAR among a growing list of Indian D2C brands that rode a funding-driven growth wave in 2021-22 and are now being re-priced as investors shift focus from top-line growth to actual profitability.
The Numbers Behind the Down Round
The markdown isn’t happening in isolation it tracks a real deterioration in the business. SUGAR’s revenue slipped to ₹404 crore in FY25, while its net loss widened to ₹135 crore over the same period. For a brand that once symbolized the D2C beauty boom, the combination of shrinking revenue and growing losses has clearly forced a valuation reset that existing backers are only now willing to formalize on paper.
Adding to the pressure, some of SUGAR’s early investors are reportedly exploring exits at steep discounts to their original entry valuations a sign that confidence in a near-term rebound is mixed even among those who backed the company early.
Why an Existing Investor, Not a New One
Notably, the entire round comes from A91 Partners, an investor already on the cap table, rather than a new backer stepping in. That detail matters: it suggests this is less a fresh vote of confidence at a re-rated valuation, and more a bridge capital meant to stabilise operations and buy the company runway to fix fundamentals, rather than fund aggressive new growth.
What This Signals for D2C Beauty
SUGAR Cosmetics was founded by Vineeta Singh and Kaushik Mukherjee and built its early reputation on bold marketing, a strong influencer and celebrity-backed growth engine, and rapid retail expansion alongside its online-first roots. Its 2022 peak valuation reflected investor enthusiasm for that scale-fast playbook.
Three years on, the story looks familiar to several other consumer brands that grew quickly on capital rather than unit economics: MamaEarth’s post-IPO stock performance and Bombay Shaving Company’s funding struggles have both drawn similar scrutiny. Investors across the board are now asking harder questions about contribution margins, customer acquisition costs, and path-to-profitability not just GMV or revenue growth.
For SUGAR, the ₹144.5 crore infusion buys time. Whether it’s enough to reverse the revenue decline and narrow losses will likely determine if this marks the bottom of the reset or just another step down.
Funding details, revenue and loss figures, and valuation numbers referenced above are based on reported figures circulating in startup/VC media coverage.
